A Study of KMV002 in Patients With mAPMR Prostate Cancer (clinicaltrials.gov) - Oct 9, 2026 - P1 | N=24 | Not yet recruiting | Sponsor: Chimivac INC
First-in-human • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|